Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Pathway Found for Treating Fatal Lung Disease
Disease Discoveries

Pathway Found for Treating Fatal Lung Disease

By Nora DunneSep 15, 2014
Share
Facebook Twitter Email
stained_lungs
The LRP5 gene correlates with pulmonary fibrosis severity. Staining of diseased lungs in mouse models with (top) and without (bottom) the Lrp5 protein.

Northwestern Medicine scientists have identified a pathway for treating a fatal lung disease that currently has no cure.

Idiopathic pulmonary fibrosis (IPF) affects 5 million people worldwide. It occurs when lung tissue scars and stiffens, making it difficult to breathe. “Idiopathic” means the cause of the chronic disease is unclear.

In a study recently published in the American Journal of Respiratory and Critical Medicine, scientists focused on a pathway called Wnt/beta-catenin that, among its many roles, is known to be critical in normal fetal development. Previous research revealed similarities between the gene expression of developing lungs and IPF lungs.

Anna Lam, MD, ’03, ’04, ’07 GME, assistant professor in Medicine-Pulmonary and Critical Care, Cara Gottardi, PhD, associate professor in Medicine-Pulmonary and Critical Care and their colleagues analyzed bloods cells from patients with the disease.

“We found that expression of genes in the Wnt/beta-catenin pathway in circulating blood cells correlated with disease progression and severity,” said Dr. Lam, first author of the study.

Anna Lam, MD, ’03, ’04, ’07 GME, assistant professor in Medicine-Pulmonary and Critical Care hopes to use this study to identify patients at risk for severe idiopathic pulmonary fibrosis.

Specifically, they discovered that overexpression of several genes in the pathway – LRP5 and LRP6 in particular – was associated with progression of IPF. Overexpression of LRP5 was also correlated with disease severity and mortality.

In mice, loss of LRP5 protected the models from developing the disease. To confirm the findings, the scientists tested a new molecule inhibitor targeting the Wnt/beta-catenin pathway and saw the same results.

Previously, the mechanisms that drove Wnt/beta-catenin signaling were unknown, as was the extent that the pathway predicted outcomes for IPF patients.

“Based on this study, we can potentially identify IPF patients at risk for the worst prognosis and disease severity by a blood test, so that new therapies targeting the Wnt/beta-catenin pathway can be used judiciously in a treatment strategy that is specifically patient-tailored,” said Dr. Lam. “Currently, no beta-catenin signaling inhibitors are yet FDA approved for use in humans. Once approved, however, our study suggests that such compounds might slow the progression of this disease.”

This study was supported by NIH grants K08HL093216, P30HL101292, HL095397, GM076561 and HL094643, in addition to Department of Defense grant W81XWH-12-1-0471.

For more information about treating pulmonary fibrosis, contact the Interstitial Diseases and Pulmonary Fibrosis Program at Northwestern Medicine.

Pulmonology Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.